Cochrane Abstracts
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lamotrigine Versus Carbamazepine Monotherapy for Epilepsy: an Individual Participant Data Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436122/all/Lamotrigine_versus_carbamazepine_monotherapy_for_epilepsy:_an_individual_participant_data_review.
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436122/all/Lamotrigine_versus_carbamazepine_monotherapy_for_epilepsy:_an_individual_participant_data_review. Accessed December 2, 2024.
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436122/all/Lamotrigine_versus_carbamazepine_monotherapy_for_epilepsy:_an_individual_participant_data_review
Lamotrigine Versus Carbamazepine Monotherapy for Epilepsy: an Individual Participant Data Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436122/all/Lamotrigine_versus_carbamazepine_monotherapy_for_epilepsy:_an_individual_participant_data_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
ID - 436122
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436122/all/Lamotrigine_versus_carbamazepine_monotherapy_for_epilepsy:_an_individual_participant_data_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
